| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $929.4M | +32.1% |
| Cost of Revenue | $172.9M | +35.4% |
| Gross Profit | $756.6M | +31.4% |
| R&D Expense | $156.3M | +40.3% |
| SG&A Expense | $126.6M | +37.3% |
| Operating Income | $81.3M | -11.5% |
| Interest Expense | $10.2M | -28.3% |
| Pre-tax Income | $71.7M | -8.0% |
| Income Tax | $19.2M |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $463.0M | +42.5% |
| Accounts Receivable | $350.7M | +44.9% |
| Current Assets | $948.4M | +39.4% |
| Total Assets | $2.54B | +12.6% |
| Current Liabilities | $865.6M | +33.6% |
| Long-term Debt | $273.9M | -30.1% |
| Total Liabilities | $1.24B | +8.2% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $250.9M | +13.8% |
| Capital Expenditures | $17.7M | +25.7% |
| Investing Cash Flow | -$30.9M | -122.6% |
| Financing Cash Flow | -$80.7M | +17.5% |
| Free Cash Flow | $233.2M | +13.0% |
| +798.0% |
| Net Income | $52.5M | -30.7% |
| EPS (Basic) | $0.18 | -33.3% |
| EPS (Diluted) | $0.18 | -30.8% |
| Stockholders' Equity |
| $1.30B |
| +17.1% |